TY - JOUR
T1 - Update for the practicing pathologist
T2 - The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
AU - Amin, Mahul B.
AU - Smith, Steven C.
AU - Reuter, Victor E.
AU - Epstein, Jonathan I.
AU - Grignon, David J.
AU - Hansel, Donna E.
AU - Lin, Oscar
AU - Mckenney, Jesse K.
AU - Montironi, Rodolfo
AU - Paner, Gladell P.
AU - Al-Ahmadie, Hikmat A.
AU - Algaba, Ferran
AU - Ali, Syed
AU - Alvarado-Cabrero, Isabel
AU - Bubendorf, Lukas
AU - Cheng, Liang
AU - Cheville, John C.
AU - Kristiansen, Glen
AU - Cote, Richard J.
AU - Delahunt, Brett
AU - Eble, John N.
AU - Genega, Elizabeth M.
AU - Gulmann, Christian
AU - Hartmann, Arndt
AU - Langner, Cord
AU - Lopez-Beltran, Antonio
AU - Magi-Galluzzi, Cristina
AU - Merce, Jorda
AU - Netto, George J.
AU - Oliva, Esther
AU - Rao, Priya
AU - Ro, Jae Y.
AU - Srigley, John R.
AU - Tickoo, Satish K.
AU - Tsuzuki, Toyonori
AU - Umar, Saleem A.
AU - Van Der Kwast, Theo
AU - Young, Robert H.
AU - Soloway, Mark S.
N1 - Funding Information:
1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA; 2Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; 3Department of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA; 4Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA; 5Department of Pathology, University of California San Diego, San Diego, CA, USA; 6Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA; 7Section of Pathological Anatomy, Polytechnic University of Medicine, United Hospitals, Ancona, Italy; 8Department of Pathology, University of Chicago, Chicago, IL, USA; 9Pathology Section, Fundacio Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain; 10Department of Pathology, Mexican Oncology Hospital, Mexico City, Mexico; 11Institute of Pathology, University Hospital Basel, Basel, Switzerland; 12Division of Anatomic Pathology, Mayo Clinic, Rochester, MN, USA; 13Institute of Pathology, University Hospital Bonn, Bonn, Germany; 14Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA; 15Department of Pathology, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand; 16Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA; 17Department of Pathology, Beaumont Hospital, Dublin, Ireland; 18Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany; 19Institute of Pathology, Medical University Graz, Graz, Austria; 20Unit of Anatomical Pathology, Cordoba University Medical School, Faculty of Medicine, Cordoba, Spain; 21James Homer Wright Pathology Laboratories, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 22Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA; 23Department of Pathology and Genomic Medicine, The Methodist Hospital Physician Organization, Weill Cornell Medical College of Cornell University, Houston, TX, USA; 24Department Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada; 25Department of Pathology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan and 26Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA
Funding Information:
The International Consultations on Urological Diseases are international consensus meetings, supported by the World Health Organization and the Union Internationale Contre le Cancer, which have occurred since 1981. Each consultation has the goal of convening experts to review data and provide evidence-based recommendations to
Publisher Copyright:
© 2015 USCAP, Inc.
PY - 2015/5/5
Y1 - 2015/5/5
N2 - The International Consultations on Urological Diseases are international consensus meetings, supported by the World Health Organization and the Union Internationale Contre le Cancer, which have occurred since 1981. Each consultation has the goal of convening experts to review data and provide evidence-based recommendations to improve practice. In 2012, the selected subject was bladder cancer, a disease which remains a major public health problem with little improvement in many years. The proceedings of the 2nd International Consultation on Bladder Cancer, which included a 'Pathology of Bladder Cancer Work Group,' have recently been published; herein, we provide a summary of developments and consensus relevant to the practicing pathologist. Although the published proceedings have tackled a comprehensive set of issues regarding the pathology of bladder cancer, this update summarizes the recommendations regarding selected issues for the practicing pathologist. These include guidelines for classification and grading of urothelial neoplasia, with particular emphasis on the approach to inverted lesions, the handling of incipient papillary lesions frequently seen during surveillance of bladder cancer patients, descriptions of newer variants, and terminology for urine cytology reporting.
AB - The International Consultations on Urological Diseases are international consensus meetings, supported by the World Health Organization and the Union Internationale Contre le Cancer, which have occurred since 1981. Each consultation has the goal of convening experts to review data and provide evidence-based recommendations to improve practice. In 2012, the selected subject was bladder cancer, a disease which remains a major public health problem with little improvement in many years. The proceedings of the 2nd International Consultation on Bladder Cancer, which included a 'Pathology of Bladder Cancer Work Group,' have recently been published; herein, we provide a summary of developments and consensus relevant to the practicing pathologist. Although the published proceedings have tackled a comprehensive set of issues regarding the pathology of bladder cancer, this update summarizes the recommendations regarding selected issues for the practicing pathologist. These include guidelines for classification and grading of urothelial neoplasia, with particular emphasis on the approach to inverted lesions, the handling of incipient papillary lesions frequently seen during surveillance of bladder cancer patients, descriptions of newer variants, and terminology for urine cytology reporting.
UR - http://www.scopus.com/inward/record.url?scp=84928825625&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928825625&partnerID=8YFLogxK
U2 - 10.1038/modpathol.2014.158
DO - 10.1038/modpathol.2014.158
M3 - Article
C2 - 25412849
AN - SCOPUS:84928825625
VL - 28
SP - 612
EP - 630
JO - Modern Pathology
JF - Modern Pathology
SN - 0893-3952
IS - 5
ER -